Ethical issues in dementia drug development: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Alzheimer Disease and Associated Disorders

Volumn 11, Issue SUPPL. 3, 1997, Pages 26-28

  Post, Stephen G ^a   Beerman, Bjorn ^b   Brodaty, Henry ^c   Gaines, Atwood W ^d   Gauthier, Serge G ^e   Geldmacher, David S ^f   Hill, Suzanne ^g   Homma, Akira ^h   Rossor, Martin N ⁱ   Whitehouse, Peter J ^f   Winblad, Bengt ^j  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Swedish Drug Agency   (Sweden)

^c Prince Henry Hospital   (Australia)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g THERAPEUTIC GOODS ADMINISTRATION   (Australia)

^h TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

ⁱ NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NOOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; CULTURAL FACTOR; DEMENTIA; DRUG FORMULATION; GERIATRIC ASSESSMENT; HUMAN; MEDICAL ETHICS; PRACTICE GUIDELINE; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; CROSS-CULTURAL COMPARISON; DEMENTIA; DRUG COMPOUNDING; ETHICS, PHARMACY; GERIATRIC ASSESSMENT; HUMANS; NOOTROPIC AGENTS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 0030627053     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Annas GJ, Grodin MA. The Nazi doctors and the Nuremberg code. New York: Oxford University Press, 1992.
2. Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA 1995;274:820-5.
3. High DM, Whitehouse PJ, Post SG, Berg L. Guidelines for addressing t ethical and legal issues in Alzheimer disease research: a position paper. Alzheimer Dis Assoc Disord 1994;8(Suppl 4):66-74.
4. Levine RJ. Informed consent: some challenges to the universal validity of the western model. Law Med Health Care 1991;19:207-13.
5. Marson DC, Schmitt FA, Ingram KK, Harrell LE. Determining the competency of Alzheimer patients to consent to treatment and research. Alzheimer Dis Assoc Disord 1994; 8(Suppl4):5-18.
6. Rodwin MA. Medicine, money, and morals: physicians' conflicts of interest. New York: Oxford University Press, 1993.